Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are being investigated as potential therapies for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding benefits and risks of the...

Full description

Saved in:

Bibliographic Details
Published in:	Cochrane database of systematic reviews Vol. 5; p. CD013600
Main Authors:	Piechotta, Vanessa, Iannizzi, Claire, Chai, Khai Li, Valk, Sarah J, Kimber, Catherine, Dorando, Elena, Monsef, Ina, Wood, Erica M, Lamikanra, Abigail A, Roberts, David J, McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J, Skoetz, Nicole
Format:	Journal Article
Language:	English
Published:	England 20.05.2021
Subjects:	Bias Cause of Death COVID-19 - mortality COVID-19 - therapy COVID-19 Serotherapy Humans Immunization, Passive - adverse effects Immunization, Passive - methods Immunization, Passive - mortality Immunization, Passive - statistics & numerical data Non-Randomized Controlled Trials as Topic - statistics & numerical data Pandemics Randomized Controlled Trials as Topic - statistics & numerical data Respiration, Artificial - statistics & numerical data Treatment Outcome Ventilator Weaning - statistics & numerical data
ISSN:	1469-493X, 1469-493X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!